GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (TSXV:RX) » Definitions » Cyclically Adjusted PB Ratio

Biosyent (TSXV:RX) Cyclically Adjusted PB Ratio : 4.36 (As of Apr. 28, 2024)


View and export this data going back to 1979. Start your Free Trial

What is Biosyent Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Biosyent's current share price is C$8.51. Biosyent's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was C$1.95. Biosyent's Cyclically Adjusted PB Ratio for today is 4.36.

The historical rank and industry rank for Biosyent's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSXV:RX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.16   Med: 13.59   Max: 98.08
Current: 4.37

During the past years, Biosyent's highest Cyclically Adjusted PB Ratio was 98.08. The lowest was 4.16. And the median was 13.59.

TSXV:RX's Cyclically Adjusted PB Ratio is ranked worse than
81.14% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs TSXV:RX: 4.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biosyent's adjusted book value per share data for the three months ended in Dec. 2023 was C$2.961. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$1.95 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biosyent Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biosyent's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Cyclically Adjusted PB Ratio Chart

Biosyent Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.39 7.70 6.33 4.28 4.74

Biosyent Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.28 4.36 4.15 4.16 4.74

Competitive Comparison of Biosyent's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyent's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biosyent's Cyclically Adjusted PB Ratio falls into.



Biosyent Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biosyent's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=8.51/1.95
=4.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyent's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Biosyent's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.961/125.4675*125.4675
=2.961

Current CPI (Dec. 2023) = 125.4675.

Biosyent Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.395 98.604 0.503
201406 0.459 99.473 0.579
201409 0.534 99.394 0.674
201412 0.589 98.367 0.751
201503 0.663 99.789 0.834
201506 0.724 100.500 0.904
201509 0.811 100.421 1.013
201512 0.867 99.947 1.088
201603 0.938 101.054 1.165
201606 1.012 102.002 1.245
201609 1.104 101.765 1.361
201612 1.162 101.449 1.437
201703 1.224 102.634 1.496
201706 1.337 103.029 1.628
201709 1.431 103.345 1.737
201712 1.531 103.345 1.859
201803 1.615 105.004 1.930
201806 1.734 105.557 2.061
201809 1.829 105.636 2.172
201812 1.912 105.399 2.276
201903 1.896 106.979 2.224
201906 1.795 107.690 2.091
201909 1.860 107.611 2.169
201912 1.906 107.769 2.219
202003 1.952 107.927 2.269
202006 1.959 108.401 2.267
202009 2.039 108.164 2.365
202012 2.093 108.559 2.419
202103 2.184 110.298 2.484
202106 2.268 111.720 2.547
202109 2.359 112.905 2.621
202112 2.513 113.774 2.771
202203 2.581 117.646 2.753
202206 2.654 120.806 2.756
202209 2.713 120.648 2.821
202212 2.758 120.964 2.861
202303 2.763 122.702 2.825
202306 2.779 124.203 2.807
202309 2.923 125.230 2.929
202312 2.961 125.468 2.961

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biosyent  (TSXV:RX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biosyent Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biosyent's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyent (TSXV:RX) Business Description

Industry
Traded in Other Exchanges
Address
2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.

Biosyent (TSXV:RX) Headlines

No Headlines